(Q37130458)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18393602%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

Tenets of protection from progression to AIDS: lessons from the immune responses to HIV-2 infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18393602%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

0 references

Aleksandra Leligdowicz

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18393602%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Sarah Rowland-Jones

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18393602%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18393602%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18393602%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18393602%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18393602%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

319-331

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18393602%20AND%20SRC:MED&resulttype=core&format=json

Isolation of a new human retrovirus from West African patients with AIDS.

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Population migration and the spread of types 1 and 2 human immunodeficiency viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

9-year HIV-2-associated mortality in an urban community in Bissau, west Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Rate of decline of percentage CD4+ cells is faster in HIV-1 than in HIV-2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Reduced rate of disease development after HIV-2 infection as compared to HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Is HIV-2- induced AIDS different from HIV-1-associated AIDS? Data from a West African clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Natural protection against HIV-1 infection provided by HIV-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Lack of protection against HIV-1 infection among women with HIV-2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Comparison of the frequency of interleukin (IL)-2-, interferon-gamma-, and IL-4-producing T cells in 2 diseases, human immunodeficiency virus types 1 and 2, with distinct clinical outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Human immunodeficiency virus (HIV)-2-specific T lymphocyte proliferative responses in HIV-2-infected and in HIV-2-exposed but uninfected individuals in Guinea-Bissau

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Natural killer cell function is well preserved in asymptomatic human immunodeficiency virus type 2 (HIV-2) infection but similar to that of HIV-1 infection when CD4 T-cell counts fall.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Proliferative, IFNgamma and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Polyfunctional T cell responses are a hallmark of HIV-2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Declining HIV-2 prevalence and incidence among men in a community study from Guinea-Bissau

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Sixteen years of HIV surveillance in a West African research clinic reveals divergent epidemic trends of HIV-1 and HIV-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Simian immunodeficiency virus infection in free-ranging sooty mangabeys (Cercocebus atys atys) from the Taï Forest, Côte d'Ivoire: implications for the origin of epidemic human immunodeficiency virus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Tracing the origin and history of the HIV-2 epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Slower heterosexual spread of HIV-2 than HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

HIV-2-infected individuals with undetectable plasma viremia carry replication-competent virus in peripheral blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Long-term intrapatient viral evolution during HIV-2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Dendritic-cell interactions with HIV: infection and viral dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

HIV preferentially infects HIV-specific CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Genome organization and transactivation of the human immunodeficiency virus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

HIV-2 and T cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

NK cells in HIV infection: paradigm for protection or targets for ambush

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5alpha alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

HIV pathogenesis: the first cut is the deepest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

T cells and viral persistence: lessons from diverse infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

HIV disease: fallout from a mucosal catastrophe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

The generation of protective memory-like CD8+ T cells during homeostatic proliferation requires CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Understanding the benign nature of SIV infection in natural hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Severe depletion of mucosal CD4+ T cells in AIDS-free simian immunodeficiency virus-infected sooty mangabeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

The conserved carboxy terminus of the capsid domain of human immunodeficiency virus type 1 gag protein is important for virion assembly and release

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Cellular immune responses to HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Immunological predictors of survival in HIV type 2-infected rural villagers in Guinea-Bissau

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Distinct profile of T cell activation in HIV type 2 compared to HIV type 1 infection: differential mechanism for immunoprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Reduced immune activation and T cell apoptosis in human immunodeficiency virus type 2 compared with type 1: correlation of T cell apoptosis with beta2 microglobulin concentration and disease evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Differential regulation of human immunodeficiency viruses (HIVs): a specific regulatory element in HIV-2 responds to stimulation of the T-cell antigen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Primary sooty mangabey simian immunodeficiency virus and human immunodeficiency virus type 2 nef alleles modulate cell surface expression of various human receptors and enhance viral infectivity and replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Nef-Mediated Suppression of T Cell Activation Was Lost in a Lentiviral Lineage that Gave Rise to HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Antibody neutralization and escape by HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Broad cross-neutralizing activity in serum is associated with slow progression and low risk of transmission in primate lentivirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Activity of non-nucleoside reverse transcriptase inhibitors against HIV-2 and SIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Polymorphism and drug-selected mutations in the protease gene of human immunodeficiency virus type 2 from patients living in Southern France

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Virological and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Highly active antiretroviral therapy and viral response in HIV type 2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

Differential Immunogenicity of HIV‐1 Clade C Proteins in Eliciting CD8+and CD4+Cell Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

CD8+ T-cell responses to different HIV proteins have discordant associations with viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

HIV-2 does not protect against HIV-1 infection in a rural community in Guinea-Bissau

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

HIV-specific cytotoxic T lymphocytes in seropositive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.319

21 January 2018

Identifiers

DOI

10.1586/14760584.7.3.319

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18393602%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference